Citigroup Inc Biora Therapeutics, Inc. Transaction History

Citigroup Inc

  • $169 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$0.56 - $1.22 $9,498 - $20,692
-16,961 Reduced 94.29%
1,027 $1,000
Q1 2022

May 12, 2022
SELL
$1.11 - $2.25 $6,514 - $13,205
-5,869 Reduced 24.6%
17,988 $21,000
Q4 2021

Feb 10, 2022
BUY
$1.35 - $4.89 $32,206 - $116,660
23,857 New
23,857 $50,000

Others Institutions Holding BIOR

# of Institutions
2
Shares Held
890
Call Options Held
0
Put Options Held
0
View Full List

About BIORA THERAPEUTICS, INC.

BIOR Quotes by TradingView
  • Ticker BIOR
  • Exchange NASDAQ
  • Shares Outstandng 186,623,605
  • Market Cap $299M
  • Description
  • Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...
More about BIOR
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email